scholarly article | Q13442814 |
P50 | author | Jeroen L Pennings | Q58366852 |
Peter C J I Schielen | Q88024799 | ||
Jacqueline E Siljee | Q96049913 | ||
P2093 | author name string | Annemieke de Vries | |
Wendy Rodenburg | |||
Sylwia Kuc | |||
Sandra Imholz | |||
P2860 | cites work | ADAM12: a novel first-trimester maternal serum marker for Down syndrome. | Q34285873 |
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction | Q34647428 | ||
Antibody-based microarrays | Q37391405 | ||
Impact of blood collection method on first-trimester dried blood free Beta hCG and PAPP-A. | Q39027543 | ||
Quantitative performance of antibody array technology in a prenatal screening setting | Q39692651 | ||
The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spots | Q39786440 | ||
Placental protein 13 as a first trimester screening marker for aneuploidy | Q44807292 | ||
Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome | Q46169856 | ||
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). | Q47860634 | ||
Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. | Q51773716 | ||
Choosing near-linear parameters in the four-parameter logistic model for radioligand and related assays. | Q52629105 | ||
First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis | Q71683035 | ||
First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes | Q80473260 | ||
PAPP-A and free ss-hCG stability in first trimester serum using PerkinElmer AutoDELFIA and DELFIA Xpress systems | Q82258440 | ||
Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation | Q83438723 | ||
Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin | Q86174676 | ||
Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes | Q87113935 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 509821 | |
P577 | publication date | 2014-07-15 | |
P1433 | published in | Disease Markers | Q15756044 |
P1476 | title | Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting | |
P478 | volume | 2014 |
Q38923334 | Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin (β-hCG) from a low-resource setting |
Q53697948 | Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women |
Search more.